Event:	Mizuho Therapeutics Conference
Date/Time:	Wednesday, September 21, 2016
Location:	Langham Hotel, Boston, MA

Related Posts

Anavex Life Sciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference
November 25, 2020

Proof of Concept Controlled Phase 2 Clinical Trial Data Evaluating ANAVEX®2-73 (blarcamesine) in Parkinson’s Disease Dementia Presented at CTAD 2020 Conference
November 6, 2020

Anavex Life Sciences Announces Positive Results from Proof of Concept controlled Phase 2 Clinical Trial Evaluating ANAVEX®2-73 (blarcamesine) in Parkinson’s Disease Dementia
October 15, 2020

Anavex Life Sciences Announces Completion of ANAVEX®2-73 (blarcamesine) U.S. Phase 2 Rett Syndrome Clinical Trial
September 10, 2020